Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 116.6
2 %
$ 145 B
Market Cap
25.29
P/E
GILD - TOTAL EQUITY
Total Equity GILD - Gilead Sciences, Inc.
22.7 B
LAST VALUE
3.94%
2 YEAR CAGR
0.97%
5 YEAR CAGR
6.50%
10 YEAR CAGR